Clinical Characteristics and Prognostic Factors of Patients With COVID-19

Coronavirus Clinical Trial

Official title:

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 in Chibi Hospital of Hubei Province

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04328454
• Other study ID #: HBCBH-IEC-2020-101
• Status: Recruiting
• Start date: January 30, 2020
• Est. completion date: April 15, 2020

Study information

• Verified date: March 2020
• Source: Shanghai 10th People's Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Description:

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 120
• Est. completion date: April 15, 2020
• Est. primary completion date: April 2, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adult aged >=18years old; Diagnosed with CONVID19. Diagnostic criteria including:

Laboratory (RT-PCR) confirmed SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral pneumonia.

Exclusion Criteria:

• Near-death state (expected survival time less than 24 hours); Malignant tumor; Pregnancy or puerperium women; Patients who refused to participant.

Related Conditions & MeSH terms

• Coronavirus
• Coronavirus Infections

Intervention

Other:
• retrospective analysis
The investigators retrospectively analyzed the hospitalized patients with COVID-19

Locations

Country	Name	City	State
China	Shanghai 10th People's Hospital	Shanghai	Shanghai

Sponsors (2)

Lead Sponsor	Collaborator
Shanghai 10th People's Hospital	Chibi People's Hospital, Hubei Province

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time to negative conversion of severe acute respiratory syndrome coronavirus 2	The primary outcome is the time to negative conversion of coronavirus	1 month
Secondary	Length of stay in hospital	The time of hospitalization	1 month
Secondary	Survival	The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked. The rate of survival within hospitalization of these patients will be tracked.	1 month
Secondary	Intubation	The rate of intubation within hospitalization of these patients will be tracked	1 month